tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Smart Value
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

RYZB

RayzeBio, Inc. Completes Merger and Delists from Nasdaq
Company AnnouncementsRayzeBio, Inc. Completes Merger and Delists from Nasdaq
1y ago
8K
RYZB
Bristol Myers completes acquisition of RayzeBio
PremiumThe Fly
Bristol Myers completes acquisition of RayzeBio
1y ago
BMY
RYZB
Bristol Myers announces expiration of tender offer for RayzeBio
PremiumThe Fly
Bristol Myers announces expiration of tender offer for RayzeBio
1y ago
BMY
RYZB
The biopharmaceuticals stocks to own in 2024, according to BofA
PremiumThe Fly
The biopharmaceuticals stocks to own in 2024, according to BofA
1y ago
BMY
JNJ
Bristol Myers downgraded to Neutral at BofA as more clarity on execution awaited
PremiumThe Fly
Bristol Myers downgraded to Neutral at BofA as more clarity on execution awaited
1y ago
BMY
KRTX
RayzeBio downgraded to Neutral from Overweight at JPMorgan
PremiumThe FlyRayzeBio downgraded to Neutral from Overweight at JPMorgan
1y ago
BMY
RYZB
RayzeBio downgraded to Hold from Buy at Truist
Premium
The Fly
RayzeBio downgraded to Hold from Buy at Truist
1y ago
BMY
FUSN
Gracell downgrade, Fusion upgrade: Wall Street’s top analyst calls
Premium
The Fly
Gracell downgrade, Fusion upgrade: Wall Street’s top analyst calls
1y ago
AZN
LLY
Recent M&A activity bodes well for Fusion Pharmaceuticals, says Oppenheimer
PremiumThe Fly
Recent M&A activity bodes well for Fusion Pharmaceuticals, says Oppenheimer
1y ago
BMY
LLY
Fusion Pharmaceuticals upgraded at Raymond James amid radiopharma M&A
PremiumThe Fly
Fusion Pharmaceuticals upgraded at Raymond James amid radiopharma M&A
1y ago
BMY
LLY
RayzeBio deal another ‘incremental positive’ for Bristol, says Morgan Stanley
PremiumThe Fly
RayzeBio deal another ‘incremental positive’ for Bristol, says Morgan Stanley
1y ago
BMY
KRTX
Cantor says Bristol joins ‘radiopharmaceuticals race’ with RayzeBio deal
PremiumThe Fly
Cantor says Bristol joins ‘radiopharmaceuticals race’ with RayzeBio deal
1y ago
BMY
LLY
Bristol Myers price target lowered to $68 from $72 at BofA
PremiumThe FlyBristol Myers price target lowered to $68 from $72 at BofA
1y ago
BMY
RYZB
RayzeBio downgraded to Market Perform from Outperform at William Blair
Premium
The Fly
RayzeBio downgraded to Market Perform from Outperform at William Blair
1y ago
RYZB
M & A News: Bristol-Myers Squibb (NYSE:BMY) to Buy RayzeBio for $4.1B
Premium
Market News
M & A News: Bristol-Myers Squibb (NYSE:BMY) to Buy RayzeBio for $4.1B
1y ago
AZN
BMY
RayzeBio jumps 99% to $60.96 after Bristol Myers takeover deal
PremiumThe Fly
RayzeBio jumps 99% to $60.96 after Bristol Myers takeover deal
1y ago
BMY
RYZB
Bristol Myers to acquire RayzeBio for $62.50 per share in cash
PremiumThe Fly
Bristol Myers to acquire RayzeBio for $62.50 per share in cash
1y ago
BMY
RYZB
RayzeBio to resume trading at 7:30 am ET
PremiumThe Fly
RayzeBio to resume trading at 7:30 am ET
1y ago
RYZB
Bristol Myers to acquire RayzeBio for $62.50 per share in cash
PremiumThe Fly
Bristol Myers to acquire RayzeBio for $62.50 per share in cash
1y ago
BMY
RYZB
Bristol Myers to acquire RayzeBio for $62.50 per share in cash
PremiumThe FlyBristol Myers to acquire RayzeBio for $62.50 per share in cash
1y ago
BMY
RYZB
Eight new option listings and one option delisting on November 8th
Premium
The Fly
Eight new option listings and one option delisting on November 8th
1y ago
ISPR
PTEC
RayzeBio announces FDA selected RYZ101 into CMC CDRP program
Premium
The Fly
RayzeBio announces FDA selected RYZ101 into CMC CDRP program
1y ago
RYZB

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >